Backtested Scanners
Organic Hypergrowth in an Uptrend
Read the study: Organic Hypergrowth: 18.13% a Year — Acquired Hypergrowth Loses Money
Read the study: Hypergrowth: One in Four Buys Fires in a Confirmed Downtrend
4 Hits · last calculated August 8, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 4 hits from US
Methodology & criteria
Revenue doubling within roughly 6 quarters — but only when the growth is home-grown (no acquisition spree, no goodwill jump) and the price is in an uptrend: above a rising 150-day line and no more than 25 % below the 52-week high. Backtested over 2013 to 2026 across 134 entries: on a twelve-month holding period 25.4 % per year versus 18.1 % for the same companies without the two trend filters, at a maximum drawdown of 47.3 % instead of 52.1 %. On three- and six-month holding periods the trend filter costs return instead. Studies: /articles/organic-hypergrowth-study (the revenue signal) and /articles/organic-hypergrowth-stage-study (the trend filter on top)
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Hit List
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA Liquidia Technologies Inc | 08/11 | +241 % | 93 9/22 | Stage 2 | A 75 | 7 of 9 | 8.0 $ | Drug Manufacturers - Specialty & Generic | Neutral | — | — | Healthcare | 90.20 $ | +114.7 % | +109.9 % | +369.7 % | −1.7 % | -4.0 % | 98 | 42 | 6.2 % | 6.4 % | 0.57 | 539.2 | 21.2 | 27.8 | 75.1 | 194.6 | — | 138.3 | 46.3 % | 91.8 % | 7.7 % | 28.2 % | 9.0 % | 1.70 | 27.0 % | +1,031.2 % | 6 | 0.0 % | 0.0 % | 2.9 | 70.2 % | 17.2 % | 4.3 (10) |
| CRDO Credo Technology Group Holding Ltd | 09/02 | +487 % | 72 7/25 | Stage 2 | A 87 | 7 of 9 | 46.5 $ | Semiconductors | Sells AI | — | Technology | 249.90 $ | +89.0 % | +63.6 % | +108.6 % | −13.2 % | +17.4 % | 96 | 93 | 10.5 % | 11.3 % | 3.23 | 101.1 | 35.1 | 34.8 | 22.7 | 114.2 | — | 77.5 | 35.7 % | 68.0 % | 35.4 % | 34.4 % | 17.9 % | 0.01 | 89.9 % | +205.7 % | 9 | 0.0 % | 0.0 % | 19.7 | 75.9 % | 3.6 % | 4.6 (13) | |
| SITM Sitime Corporation | 08/05 | +172 % | 72 7/25 | Stage 2 | A 83 | 7 of 9 | 20.4 $ | Semiconductors | Sells AI | — | — | Technology | 725.30 $ | +100.1 % | +87.9 % | +264.8 % | −25.1 % | +43.6 % | 95 | 12 | 8.0 % | 7.5 % | 2.87 | — | 71.9 | 43.6 | 16.4 | 242.2 | 3.82 | 3,075.7 | -4.2 % | 55.7 % | -6.4 % | -2.6 % | -2.3 % | 0.00 | 89.6 % | +61.2 % | 5 | 0.0 % | 0.0 % | 16.1 | 89.0 % | 5.0 % | 3.9 (7) |
| ATLC Atlanticus Holdings Corporation | 08/06 | +51 % | 41 4/22 | Stage 2 | B 69 | 6 of 9 | 1.5 $ | Credit Services | Uses AI | — | Financial Services | 100.00 $ | +51.4 % | +49.6 % | +101.6 % | −2.8 % | +16.6 % | 90 | 77 | 6.3 % | 6.0 % | 2.12 | — | 7.9 | 0.8 | — | 1.6 | — | 0.0 | — | 72.4 % | 21.4 % | 21.4 % | 2.5 % | — | — | +53.3 % | 7 | 0.0 % | 0.0 % | 4.5 | 25.0 % | 25.8 % | 4.3 (7) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Revenue doubling within roughly 6 quarters — but only when the growth is home-grown (no acquisition spree, no goodwill jump) and the price is in an uptrend: above a rising 150-day line and no more than 25 % below the 52-week high.
All scanners are recalculated daily across the entire stock universe — most recently on 8. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 4 stocks pass this scanner's criteria (as of 8. August 2026).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.